Extensive Extranodal Involvement of Rare Sites in Non Hodgkin's Lymphoma Detected on 18F- FDG PET-CT: A Case Report

被引：10

作者：

Dhull V.S. ^{[1
]}

Sharma P. ^{[1
]}

Singla S. ^{[1
]}

Faizi N.A. ^{[1
,2
]}

Thulkar S. ^{[2
]}

Bal C. ^{[1
]}

Kumar R. ^{[1
]}

机构：

[1] Department of Nuclear Medicine, All India Institute of Medical Sciences, New Delhi, 110029, Ansari Nagar

[2] Department of Radiodiagnosis, All India Institute of Medical Sciences, New Delhi

来源：

Nuclear Medicine and Molecular Imaging | 2013年 / 47卷 / 2期

关键词：

!sup]18[!/sup]F-FDG; Atria; Extranodal; Kidneys; Non Hodgkin's lymphoma; PET-CT; Testis;

D O I：

10.1007/s13139-012-0183-3

中图分类号：

学科分类号：

摘要：

We present a case of a 23 year-old male treated for Hodgkin's lymphoma who developed diffuse large B-cell lymphoma (DLBCL) 8 years after achieving remission. 18F-fluorodeoxyglucose positron emission tomography computed tomography (18F-FDG PET-CT) was done, which revealed extensive extranodal involvement of bilateral atria, bilateral kidneys, ileo-caecal junction and left testis along with mesenteric and retroperitoneal lymph nodal involvement. Renal and cardiac lesions were not detected by contrast-enhanced CT. Simultaneous lymphomatous involvement of rare sites such as heart, kidneys and testis in a single patient has not been reported before. © 2012 Korean Society of Nuclear Medicine.

引用

页码：125 / 129

页数：4

共 23 条

[1]

Armitage J.O., Longo D.L., Et al., Malignancies of lymphoid cells, (15): Harrison's Principles of Internal Medicine, pp. 641-655, (2005)

[2]

Paes F.M., Kalkanis D.G., Sideras P.A., Serafini A.N., FDG PET/CT of Extranodal Involvement in Non-Hodgkin Lymphoma and Hodgkin Disease, RadioGraphics, 30, pp. 269-291, (2010)

[3]

Even-Sapir E., Lievshitz G., Perry C., Herishanu Y., Lerman H., Metser U., Fluorine-18 Fluorodeoxyglucose PET/CT Patterns of Extranodal Involvement in Patients with Non-Hodgkin Lymphoma and Hodgkin's Disease, Radiol Clin N Am, 45, pp. 697-709, (2007)

[4]

Pelosi E., Pregno P., Penna D., Deandreis D., Chiappella A., Limerutti G., Et al., Role of whole-body [18F] fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT) and conventional techniques in the staging of patients with Hodgkin and aggressive non Hodgkin lymphoma, Radiol Med, 113, pp. 578-590, (2008)

[5]

Kumar R., Maillard I., Schuster S.J., Alavi A., Utility of fluorodeoxyglucose-PET imaging in the management of patients with Hodgkin's and non-Hodgkin's lymphomas, Radiol Clin North Am, 42, pp. 1083-1100, (2004)

[6]

Jerusalem G., Bequin Y., Fassotte M.F., Najjar F., Paulus P., Rigo P., Et al., Whole-body positron emission tomography using 18F-fluorodeoxyglucose for posttreatment evaluation in Hodgkin's disease and non-Hodgkin's lymphoma has higher diagnostic and prognostic value than classical computed tomography scan imaging, Blood, 15, pp. 429-433, (1999)

[7]

Specht L., 2-[18F]fluoro-2-deoxyglucose positron-emission tomography in staging, response evaluation, and treatment planning of lymphomas, Semin Radiat Oncol, 17, pp. 190-197, (2007)

[8]

Yin Y., Qing F., Li X., Du B., Li N., Li Y., Non Hodgkin's lymphoma of the testicle and bilateral adrenals detected by 18F-FDG PET/CT, Exp Theor Med, 2, pp. 817-820, (2011)

[9]

Julian A., Wagner T., Ysebaert L., Chabbert V., Payoux P., FDG PET/CT leads to the detection of metastatic involvement of the heart in non-Hodgkin'slymphoma, Eur J Nucl Med Mol Imaging, 38, (2011)

[10]

Kaderli A.A., Baran I., Aydin O., Bicer M., Akpinar T., Ozkalemkas F., Et al., Diffuse involvement of the heart and great vessels in primary cardiac lymphoma, Eur J Echocardiogr, 11, pp. 74-76, (2010)

← 1 2 3 →